Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Regorafenib market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Regorafenibmarket, defines the market attractiveness level of Regorafenib market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Regorafenib industry, describes the types of Regorafenib market, the applications of major players and the market size, and deeply analyzes the current situation of the global Regorafenib market and the development prospects and opportunities of Regorafenib industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Regorafenib market in Chapter 13.
By Player:
Bayer Pharmaceuticals
Drug International
Beacon Pharmaceuticals
By Type:
Bottled Packaging
Film Coated Packaging
By End-User:
Metastatic Colorectal Cancer
Advanced Gastrointestinal Stromal Tumours
Advanced Hepatocellular Carcinoma
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Regorafenib Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Regorafenib Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Regorafenib Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Regorafenib Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Regorafenib Market Analysis and Outlook to 2022
-
7.1 Global Regorafenib Consumption (2017-2022)
-
7.2 United States Regorafenib Consumption (2017-2022)
-
7.3 Europe Regorafenib Consumption (2017-2022)
-
7.4 China Regorafenib Consumption (2017-2022)
-
7.5 Japan Regorafenib Consumption (2017-2022)
-
7.6 India Regorafenib Consumption (2017-2022)
-
7.7 South Korea Regorafenib Consumption (2017-2022)
8 Region and Country-wise Regorafenib Market Analysis and Outlook to 2028
-
8.1 Global Regorafenib Consumption Forecast (2022-2028)
-
8.2 United States Regorafenib Consumption Forecast (2022-2028)
-
8.3 Europe Regorafenib Consumption Forecast (2022-2028)
-
8.4 China Regorafenib Consumption Forecast (2022-2028)
-
8.5 Japan Regorafenib Consumption Forecast (2022-2028)
-
8.6 India Regorafenib Consumption Forecast (2022-2028)
-
8.7 South Korea Regorafenib Consumption Forecast (2022-2028)
9 Global Regorafenib Market Outlook by Types and Applications to 2022
-
9.1 Global Regorafenib Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Bottled Packaging Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Film Coated Packaging Consumption and Growth Rate (2017-2022)
-
9.2 Global Regorafenib Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Metastatic Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Advanced Gastrointestinal Stromal Tumours Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Advanced Hepatocellular Carcinoma Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Regorafenib Market Outlook by Types and Applications to 2028
-
10.1 Global Regorafenib Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Bottled Packaging Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Film Coated Packaging Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Regorafenib Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Metastatic Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Advanced Gastrointestinal Stromal Tumours Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Advanced Hepatocellular Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Regorafenib Import and Export Analysis (Top 5 Countries)
-
11.1 Global Regorafenib Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Regorafenib Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Regorafenib Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Regorafenib Market Competitive Analysis
-
14.1 Bayer Pharmaceuticals
-
14.1.1 Bayer Pharmaceuticals Company Details
-
14.1.2 Bayer Pharmaceuticals Regorafenib Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bayer Pharmaceuticals Regorafenib Product and Service
-
14.2 Drug International
-
14.2.1 Drug International Company Details
-
14.2.2 Drug International Regorafenib Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Drug International Regorafenib Product and Service
-
14.3 Beacon Pharmaceuticals
-
14.3.1 Beacon Pharmaceuticals Company Details
-
14.3.2 Beacon Pharmaceuticals Regorafenib Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Beacon Pharmaceuticals Regorafenib Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Regorafenib
-
Figure Regorafenib Picture
-
Table Global Regorafenib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Regorafenib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Regorafenib Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Regorafenib Consumption by Country (2017-2022)
-
Figure United States Regorafenib Consumption and Growth Rate (2017-2022)
-
Table Europe Regorafenib Consumption and Growth Rate (2017-2022)
-
Figure China Regorafenib Consumption and Growth Rate (2017-2022)
-
Figure Japan Regorafenib Consumption and Growth Rate (2017-2022)
-
Figure India Regorafenib Consumption and Growth Rate (2017-2022)
-
Figure South Korea Regorafenib Consumption and Growth Rate (2017-2022)
-
Figure Global Regorafenib Consumption Forecast by Country (2022-2028)
-
Figure United States Regorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Regorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Regorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Regorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Regorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Regorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bottled Packaging Consumption and Growth Rate (2017-2022)
-
Figure Global Film Coated Packaging Consumption and Growth Rate (2017-2022)
-
Figure Global Metastatic Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Advanced Gastrointestinal Stromal Tumours Consumption and Growth Rate (2017-2022)
-
Figure Global Advanced Hepatocellular Carcinoma Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Bottled Packaging Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Film Coated Packaging Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metastatic Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Advanced Gastrointestinal Stromal Tumours Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Advanced Hepatocellular Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Regorafenib Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Regorafenib Export by Region (Top 5 Countries) (2017-2028)
-
Table Bayer Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Bayer Pharmaceuticals Regorafenib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Pharmaceuticals Regorafenib Product and Service
-
Table Drug International (Foundation Year, Company Profile and etc.)
-
Table Drug International Regorafenib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Drug International Regorafenib Product and Service
-
Table Beacon Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Beacon Pharmaceuticals Regorafenib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beacon Pharmaceuticals Regorafenib Product and Service
-
